Chimera Declares First Quarter 2025 Preferred Stock Dividends

Rhea-AI Summary

Chimera has declared its first quarter 2025 preferred stock dividends for all four series of its preferred shares. The dividends include:

- Series A (8.00%): $0.50 per share
- Series B (8.00% Fixed-to-Floating): $0.6488 per share, reflecting a 10.38139% rate
- Series C (7.75%): $0.484375 per share
- Series D (8.00% Fixed-to-Floating): $0.6231 per share, reflecting a 9.96939% rate

All dividends will be payable on March 31, 2025, to shareholders of record on March 3, 2025, with an ex-dividend date of March 3, 2025. The floating rates for Series B and D are based on three-month CME Term SOFR plus respective spreads.

Positive

• Maintained consistent dividend payments across all preferred stock series
• Series B preferred stock offers attractive 10.38139% rate
• Series D preferred stock provides competitive 9.96939% rate

Negative

• None.

Insights

Fixed Income Analyst

The declaration of Q1 2025 preferred stock dividends across Chimera's four series demonstrates the company's continued commitment to its capital structure obligations. The fixed-rate Series A at $0.50 per share (8.00%) provides a stable foundation, while the floating-rate components of Series B and D, yielding 10.38139% and 9.96939% respectively, reflect current market conditions with their SOFR-based adjustments.

The floating rate spreads of 5.791% for Series B and 5.379% for Series D, plus the SOFR adjustment of 0.26161%, indicate strong yield premiums that compensate investors for subordination risk while remaining competitive in the current rate environment. Series C's fixed rate of 7.75% rounds out a diversified preferred stock structure that balances fixed and floating rate exposure.

These consistent preferred dividend declarations signal strong liquidity management and a prioritization of preferred shareholder obligations. The maintenance of these payments, particularly in the current market environment, suggests robust cash flow generation capacity and prudent capital allocation strategies. The ex-dividend date of March 3, 2025, provides clear timing for investors managing their preferred stock positions.

• BOARD DECLARES FIRST QUARTER 2025 DIVIDEND OF $0.50 PER SHARE OF 8.00% SERIES A CUMULATIVE REDEEMABLE PREFERRED STOCK

• BOARD DECLARES FIRST QUARTER 2025 DIVIDEND OF $0.6488 PER SHARE OF 8.00% SERIES B FIXED-TO-FLOATING RATE CUMULATIVE REDEEMABLE PREFERRED STOCK

• BOARD DECLARES FIRST QUARTER 2025 DIVIDEND OF $0.484375 PER SHARE OF 7.75% SERIES C FIXED-TO-FLOATING RATE CUMULATIVE REDEEMABLE PREFERRED STOCK

• BOARD DECLARES FIRST QUARTER 2025 DIVIDEND OF $0.6231 PER SHARE OF 8.00% SERIES D FIXED-TO-FLOATING RATE CUMULATIVE REDEEMABLE PREFERRED STOCK

NEW YORK--(BUSINESS WIRE)-- The Board of Directors of Chimera announced the declaration of its first quarter cash dividend of $0.50 per share of 8.00% Series A Cumulative Redeemable Preferred Stock. The dividend is payable March 31, 2025 to preferred shareholders of record on March 3, 2025. The ex-dividend date is March 3, 2025.

The Board of Directors of Chimera also announced the declaration of its first quarter cash dividend of $0.6488 per share of 8.00% Series B Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock, which reflects a rate of 10.38139%, equal to three-month CME Term SOFR (plus a spread adjustment of 0.26161%) on the dividend determination date plus a spread of 5.791%. The dividend is payable March 31, 2025 to preferred shareholders of record on March 3, 2025. The ex-dividend date is March 3, 2025.

The Board of Directors of Chimera also announced the declaration of its first quarter cash dividend of $0.484375 per share of 7.75% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock. The dividend is payable March 31, 2025 to preferred shareholders of record on March 3, 2025. The ex-dividend date is March 3, 2025.

The Board of Directors of Chimera also announced the declaration of its first quarter cash dividend of $0.6231 per share of 8.00% Series D Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock, which reflects a rate of 9.96939%, equal to three-month CME Term SOFR (plus a spread adjustment of 0.26161%) on the dividend determination date plus a spread of 5.379%. The dividend is payable March 31, 2025 to preferred shareholders of record on March 3, 2025. The ex-dividend date is March 3, 2025.

About Chimera Investment Corporation

Chimera is a publicly traded real estate investment trust, or REIT, that is primarily engaged in the business of investing for itself and for unrelated third parties through its investment management and advisory services in a diversified portfolio of real estate assets, including residential mortgage loans, Non-Agency RMBS, Agency RMBS, business purpose and investor loans, including RTLs, MSRs, and other real estate-related assets such as Agency CMBS, junior liens and HELOCs, equity appreciation rights, and reverse mortgages.

Forward-Looking Statements

In this press release references to “we,” “us,” “our” or “the Company” refer to Chimera Investment Corporation and its subsidiaries unless specifically stated otherwise or the context otherwise indicates. This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, readers should not rely on these forward-looking statements as predictions of future events. Words such as “goal,” “expect,” “target,” “assume,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “would,” “will,” “could,” “should,” “believe,” “predict,” “potential,” “continue,” or similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from expected results, including, among other things, those described in our most recent Annual Report on Form 10-K, and any subsequent Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, under the caption “Risk Factors.” Factors that could cause actual results to differ include, but are not limited to: our ability to obtain funding on favorable terms and access the capital markets; our ability to achieve optimal levels of leverage and effectively manage our liquidity; changes in inflation, the yield curve, interest rates and mortgage prepayment rates; our ability to manage credit risk related to our investments and comply with the Risk Retention Rules; rates of default, delinquencies, forbearance, deferred payments or decreased recovery rates on our investments; the concentration of properties securing our securities and residential loans in a small number of geographic areas; our ability to execute on our business and investment strategy; our ability to determine accurately the fair market value of our assets; changes in our industry, the general economy or geopolitical conditions; our ability to successfully integrate and realize the anticipated benefits of any acquisitions, including the Palisades Acquisition; our ability to operate our investment management and advisory services and manage any regulatory rules and conflicts of interest; the degree to which our hedging strategies may or may not be effective; our ability to effect our strategy to securitize residential mortgage loans; our ability to compete with competitors and source target assets at attractive prices; our ability to find and retain qualified executive officers and key personnel; the ability of servicers and other third parties to perform their services at a high level and comply with applicable law and expanding regulations; our dependence on information technology and its susceptibility to cyber-attacks; our ability to comply with extensive government regulation; the impact of and changes in governmental regulations, tax law and rates, accounting guidance, and similar matters; our ability to maintain our exemption from registration under the Investment Company Act of 1940, as amended; our ability to maintain our classification as a real estate investment trust for U.S. federal income tax purposes; the volatility of the market price and trading volume of our shares; and our ability to make distributions to our stockholders in the future.

Readers are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. Chimera does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statement to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based. Additional information concerning these, and other risk factors is contained in Chimera’s most recent filings with the Securities and Exchange Commission (SEC). All subsequent written and oral forward-looking statements concerning Chimera or matters attributable to Chimera or any person acting on its behalf are expressly qualified in their entirety by the cautionary statements above.

Readers are advised that any financial information in this press release is based on Company data available at the time of this presentation and, in certain circumstances, may not have been audited by Chimera’s independent auditors.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250211313532/en/

Investor Relations

888-895-6557

www.chimerareit.com

Source: Chimera Investment Corporation

FAQ

What are the dividend amounts for Chimera's (CIM) preferred stock series in Q1 2025?

Chimera declared Q1 2025 dividends of $0.50 for Series A, $0.6488 for Series B, $0.484375 for Series C, and $0.6231 for Series D preferred shares.

When is the payment date for Chimera's (CIM) Q1 2025 preferred stock dividends?

All preferred stock dividends will be paid on March 31, 2025.

What is the record date for Chimera's (CIM) Q1 2025 preferred dividends?

The record date is March 3, 2025, which is also the ex-dividend date.

What are the current rates for Chimera's (CIM) floating-rate preferred stocks?

Series B has a rate of 10.38139% and Series D has a rate of 9.96939%, both based on three-month CME Term SOFR plus their respective spreads.